BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12910491)

  • 1. Segmental neurofibromatosis in childhood.
    Listernick R; Mancini AJ; Charrow J
    Am J Med Genet A; 2003 Aug; 121A(2):132-5. PubMed ID: 12910491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
    Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
    J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial unilateral lentiginosis is mosaic neurofibromatosis type 1 or not?
    Yaşar Ş; Ersanli A; Göktay F; Aytekin S; Cebeci D; Güneş P
    J Dermatol; 2017 Jan; 44(1):29-35. PubMed ID: 27439996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.
    Vannelli S; Buganza R; Runfola F; Mussinatto I; Andreacchio A; de Sanctis L
    Ital J Pediatr; 2020 May; 46(1):58. PubMed ID: 32393377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of growth hormone deficiency combined with neurofibromatosis Type 1 and its gene analysis].
    Long X; Xiong J; Mo Z; Zhang Q; Jin P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):811-815. PubMed ID: 30124220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of 58 Japanese patients with mosaic neurofibromatosis 1.
    Tanito K; Ota A; Kamide R; Nakagawa H; Niimura M
    J Dermatol; 2014 Aug; 41(8):724-8. PubMed ID: 25041723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
    Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
    J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of multiple café-au-lait macules for neurofibromatosis 1 in Chinese children.
    Yao R; Wang L; Yu Y; Wang J; Shen Y
    J Dermatol; 2016 May; 43(5):537-42. PubMed ID: 26458495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophthalmological manifestations in segmental neurofibromatosis type 1.
    Ruggieri M; Pavone P; Polizzi A; Di Pietro M; Scuderi A; Gabriele A; Spalice A; Iannetti P
    Br J Ophthalmol; 2004 Nov; 88(11):1429-33. PubMed ID: 15489488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic outcome in children with multiple café au lait spots.
    Korf BR
    Pediatrics; 1992 Dec; 90(6):924-7. PubMed ID: 1344978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of neurofibromatosis 1 (NF1) lesions by body segment.
    Palmer C; Szudek J; Joe H; Riccardi VM; Friedman JM
    Am J Med Genet A; 2004 Mar; 125A(2):157-61. PubMed ID: 14981716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial unilateral lentiginosis with ipsilateral Lisch nodules and axillary freckling.
    Chen W; Fan PC; Happle R
    Dermatology; 2004; 209(4):321-4. PubMed ID: 15539896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral segmental neurofibromatosis: a case report and review.
    Gonzalez G; Russi ME; Lodeiros A
    Pediatr Neurol; 2007 Jan; 36(1):51-3. PubMed ID: 17162198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.
    Legius E; Brems H
    Childs Nerv Syst; 2020 Oct; 36(10):2285-2295. PubMed ID: 32601904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants.
    Kehrer-Sawatzki H; Cooper DN
    Hum Genet; 2022 Feb; 141(2):177-191. PubMed ID: 34928431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemia.
    Banerjee S; Lei D; Liang S; Yang L; Liu S; Wei Z; Tang JP
    Oncotarget; 2017 Jun; 8(24):39695-39702. PubMed ID: 27980226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Unusual clinical manifestations of type 1 neurofibromatosis].
    Komlósi K; Polgár N; Hadzsiev K; Ottóffy G; Illés T; Dóczi T; Melegh B
    Orv Hetil; 2011 Dec; 152(49):1965-70. PubMed ID: 22106164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.